Volume 4, Number 4—December 1998
Synopsis
Chlamydia pneumoniae and Cardiovascular Disease
Figure 1
References
- Kuo C-C, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae. Clin Microbiol Rev. 1995;8:451–61.PubMedGoogle Scholar
- Saikku P, Mattila K, Nieminen RS, Makela PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–6. DOIPubMedGoogle Scholar
- Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V, Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med. 1992;116:273–8.PubMedGoogle Scholar
- Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993;87:1130–4.PubMedGoogle Scholar
- Grayston JT, Kuo C-C, Campbell LA, Wang SP, Jackson L. Chlamydia pneumoniae and cardiovascular disease. Cardiologia. 1997;42:1145–51.PubMedGoogle Scholar
- Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–6. DOIPubMedGoogle Scholar
- Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841–9.PubMedGoogle Scholar
- Kuo C-C, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young (15 to 35 year) adults. Proc Natl Acad Sci U S A. 1995;92:6911–4. DOIPubMedGoogle Scholar
- Campbell LA, O'Brien ER, Cappuccio AL, Kuo C-C, Wang S-P, Stewart D, Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissues. J Infect Dis. 1995;172:585–8.PubMedGoogle Scholar
- Davidson M, Kuo C-C, Middaugh JP, Campbell LA, Wang SP, Finley JC, Chlamydia pneumoniae (TWAR) in Alaska Natives with coronary atheroma. Circulation. 1998. In press.PubMedGoogle Scholar
- Ramirez J, Ahkee A, Ganzel BL, Ogden LL, Gaydos CA, Quinn TC, Isolation of Chlamydia pneumoniae (C pn) from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med. 1996;125:979–82.PubMedGoogle Scholar
- Ouchi K, Fuji B, Kanamoto Y, Miyazaki H, Nakazawa T. Detection of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries and large arteries. In: Abstracts of the 35th International Conference on Antimicrobial Agents and Chemotherapy; 1995; San Francisco, California. Abstract K-37.
- Mühlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Kargounis LA, Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555–61. DOIPubMedGoogle Scholar
- Varghese PJ, Gaydos CA, Arumugham SB, Pham DG, Quinn TC, Tuazon CU. Demonstration of Chlamydia pneumoniae in coronary atheromas specimens from young patients with normal cholesterol from the southern part of India. In: Abstracts of the 33rd Annual Meeting of the Infectious Disease Society of America; 1995; San Francisco, California; 1995. p. 53.
- Jackson LA, Campbell LA, Kuo C-C, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:292–5. DOIPubMedGoogle Scholar
- Maass M, Krause E, Kruger S, Engel PM, Barels C. Coronary arteries harbour viable C. pneumoniae [Abstract]. J Clin Infect. 1997;3(Suppl 2):136.
- Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;86:2144-8. Kuo C-C, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1992;13:1501–4.
- Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel HM, Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg. 1997;25:499–505. DOIPubMedGoogle Scholar
- Blasi F, Denti F, Erba M, Cosentini P, Raccanelli R, Rinaldi A, Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766–9.PubMedGoogle Scholar
- Ong G, Thomas BJ, Mansfield OA, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 1996;49:102–6. DOIPubMedGoogle Scholar
- Kuo C-C, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang S-P, Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg. 1997;26:1–3. DOIPubMedGoogle Scholar
- Juvonen J, Juvonen T, Laurila A, Kuusisto J, Bodai CA, Alarakkola E, Can degenerative tricuspid aortic valve stenosis be caused by a persistent Chlamydia pneumoniae infection? A study of 46 cadavers. Ann Intern Med. 1998. In press.PubMedGoogle Scholar
- Nystrom-Rosander C, Thelin S, Hjelm E, Lindquist O, Pahlson C, Friman G. High incidence of Chlamydia pneumoniae in sclerotic heart valve of patients undergoing aortic valve replacement. Scand J Infect Dis. 1997;29:361–5. DOIPubMedGoogle Scholar
- Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J. 1992;82:158–61.PubMedGoogle Scholar
- Grayston JT, Kuo C-C, Coulson AS, Campbell LA, Lawrence RD, Ming-Jong L, Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397–400.PubMedGoogle Scholar
- Jackson LA, Campbell LA, Schmidt RA, Kuo C-C, Cappuccio AL, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular and non-cardiovascular tissues: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150:1785–90.PubMedGoogle Scholar
- Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:957–96.PubMedGoogle Scholar
- Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993;14 Suppl K:2-6.
- Grönhagen-Riska M, Saikku P, Riska H, Froseth B, Grayston JT. Antibodies to TWARa novel type of Chlamydiain sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, editors. Sarcoidosis and other granulomatous disorders. Amsterdam: Excerpta Medica; 1988. p. 297-301.
- Godzik K, O'Brien ER, Wang S-W, Kuo C-C. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 1995;33:2411–4.PubMedGoogle Scholar
- Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun. 1996;64:1614–20.PubMedGoogle Scholar
- Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998;177:725–9. DOIPubMedGoogle Scholar
- Yang Y-S, Cummings PK, Patton DL, Kuo C-C. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis. 1994;170:464–7.PubMedGoogle Scholar
- Moazed TC, Kuo CC, Grayston JT, Campbell LA. An experimental rabbit model of Chlamydia pneumoniae infection. Am J Pathol. 1996;148:667–76.PubMedGoogle Scholar
- Moazed TC, Kuo C-C, Grayston JT, Campbell LA. Evidence of systemic dissemination of C. pneumoniae infection via macrophages in the mouse. J Infect Dis. 1998;177:1322–5. DOIPubMedGoogle Scholar
- Fryer RH, Schwobe EP, Woods ML, Rodgers GM. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med. 1997;45:168–74.PubMedGoogle Scholar
- Molestina RE, Dean D, Ramirez JA, Summersgill JT. Characterization of a strain Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect Immun. 1998;66:1360–76.
- Kaukoranta-Rolvanen SS, Ronni T, Leinonen M, Saikku P, Laitinen K. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog. 1996;21:407–11. DOIPubMedGoogle Scholar
- Heinemann M, Susa M, Simnacher U, Marre R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun. 1996;64:4872–87.PubMedGoogle Scholar
- Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997;35:48–52.PubMedGoogle Scholar
- Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997;65:4832–5.PubMedGoogle Scholar
- Moazed TC, Kuo C-C, Grayston JT, Campbell LA. Murine Models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis. 1997;175:883–90. DOIPubMedGoogle Scholar
- Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo C-C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in ApoE-deficient mice. In: Stephens RS, Byrne GI, Christiansen G, Clark I, Grayston JT, Hatch T, et al., editors. Chlamydial Infections-1998: Proceedings of the 9th International Symposium on Human Chlamydial Infections; 1998 Jun 21-26; Napa, California. In Press 1998.
- Malinverni R, Kuo C-C, Campbell LA, Grayston JT. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis. 1995;172:593–4.PubMedGoogle Scholar
- Laitinen K, Laurila AL, Leinonen M, Saikku P. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun. 1996;:1488–90.PubMedGoogle Scholar
- Malinverni R, Kuo C-C, Campbell LA, Lee A, Grayston JT. Experimental Chlamydia pneumoniae (TWAR) pneumonitis: effect of two antibiotic regimens on the course and persistence of infection. Antimicrob Agents Chemother. 1995;39:45–9.PubMedGoogle Scholar
- Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97:633–6.PubMedGoogle Scholar
- Gupta S, Leatham EW, Carrington D, Mendell MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation. 1997;46:404–7.
- Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 1997;350:404–7. DOIPubMedGoogle Scholar
- Jackson LA, Wang S-P, Douglas K, Cooke DB, Grayston JT. Azithromycin treatment following percutaneous coronary revascularization procedures: a pilot study. Detection of Chlamydia pneumoniae bacteremia in patients with symptomatic coronary atherosclerosis. In: Abstracts of the 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides; 1998; Barcelona, Spain. 1998; Abstract 4.16.
- Grayston JT. Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events [editorial]. Circulation. 1998;97:1669–70.PubMedGoogle Scholar
- Muhlestein JB, Carlquist JF, Hammond EH, Radicke E, Thomson MJ, Trehan C, Detection of Chlamydia pneumoniae in patients with symptomatic coronary atherosclerosis [abstract]. J Investig Med.;45:142A.
Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.